Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.
Since Nov 18, 2025
Transactions
11
Purchases
5
Sales
6
Purchase value
$325.25K
Sale value
$676.75K
Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.
Graham D. ReeveCOO
4
Filed Nov 17, 2026Period of report Nov 16, 20260000885978-26-000080
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 16, 2026
Common StockF1F2
1,792
$99.42
$178.16K
26,762
Direct
Filing footnotes · 2
F1The price reported $99.42 is the weighted average price. The shares were purchased in multiple transactions at prices ranging from $99.16 to $99.57 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2Includes 17,488 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 1,948 shares will vest on November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates.
Filed Sep 14, 2026Period of report Jun 12, 20260001193125-26-390608
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseSep 11, 2026
Common StockF3F2
5.27
$79.00
$416.33
3,217.14
Direct
PurchaseJun 12, 2026
Common StockF1F2
0.87
$66.50
$57.86
3,211.87
Direct
Filing footnotes · 3
F1Represents a fractional share acquired through the automatic reinvestment of cash dividends in the Reporting Person's brokerage account. This transaction was inadvertently not reported previously and is being reported on this Form 4.
F2Includes 1,153 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as follows: 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.
F3Represents shares acquired through automatic reinvestment of cash dividends in the Reporting Person's brokerage account.
Filed Jun 10, 2026Period of report Jun 8, 20260001193125-26-266197
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseJun 9, 2026
Common StockF1
288
$61.50
$17.71K
3,211
Direct
PurchaseJun 8, 2026
Common StockF1
492
$63.14
$31.06K
2,923
Direct
Filing footnotes · 1
F1Includes 2,306 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,153 shares on August 20, 2026, 576 shares on November 20, 2026 and 577 shares on March 6, 2027, if he is a director of the Company on those dates.
Filed Mar 12, 2026Period of report Mar 11, 20260001193125-26-104315
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 11, 2026
Common StockF1F2
662
$78.86
$52.21K
30,078
Direct
Filing footnotes · 2
F1The price reported ($78.86) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $78.82 to $79.82 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2Includes 21,384 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,948 shares will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates.
Filed Mar 11, 2026Period of report Mar 6, 20260001193125-26-102296
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 9, 2026
Common Stock
1
$78.52
$78.52
0
IndirectReeve Trust
SaleMar 6, 2026
Common Stock
1,807
$82.25
$148.63K
1
IndirectReeve Trust
Filing footnotes · 1
F1Includes 21,384 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 1,948 shares will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 1,956 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates.
Filed Mar 9, 2026Period of report Mar 6, 20260001193125-26-098618
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 6, 2026
Common StockF1
3,000
$81.64
$244.92K
24,867
Direct
Filing footnotes · 1
F1Includes 21,070 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as to 1,870 shares will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, 1,876 shares will vest on March 6, 2027, 1,636 shares will vest on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,640 shares will vest on March 6, 2028, 1,130 shares will vest on each of May 20, 2028, August 20, 2028, and November 20, 2028, 1,134 shares will vest on March 6, 2029, 624 shares will vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 640 shares will vest on March 6, 2030, if he is an employee of the Company on those dates.
Filed Nov 25, 2025Period of report Nov 24, 20250001193125-25-297192
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleNov 24, 2025
Common StockF1F2
743
$71.01
$52.76K
20,740
Direct
Filing footnotes · 2
F1The price reported $71.01 is the weighted average price. The shares were sold in multiple transactions at prices ranging from $71.01 to $71.31 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2Includes 13,348 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,964 shares on March 6, 2026, 1,324 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,332 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates.
Filed Nov 24, 2025Period of report Nov 20, 20250001193125-25-293697
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseNov 20, 2025
Common StockF1
4,000
$69.00
$276.00K
24,786
Direct
Filing footnotes · 1
F1Includes 471 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. These shares will fully vest on March 6, 2026 if she remains as a member of the Board of Directors of the Company on that date.
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.